Dr. Robin Carhart-Harris’ Pioneering Research and the Effects of Psychedelic Therapy on Mental Health

Dr. Robin Carhart-Harris is an internationally acclaimed leader in psychedelic research, pioneering ground-breaking studies that have significantly advanced our understanding of substances such as psilocybin, LSD and MDMA as therapeutic agents. As head of Imperial College London’s Centre for Psychedelic Research he has played a crucial role in changing perceptions about these psychedelic substances as […]

A Guide to Navigating the Legal Landscape of Psychedelics in the US

The legal landscape of psychedelics in the United States has been experiencing significant changes in recent years, as the benefits of these substances for mental health treatment and personal growth become more widely recognized. As the laws surrounding psychedelics continue to evolve, it is essential for those interested in using these substances to stay informed […]

Current Landscape and Key Players in the Psychedelic Market

IntroductionThe psychedelic market has changed substantially in the last decade, thanks to rising acceptance for therapeutic use as well as investment into research and development. Exploring its current landscape and key players shaping it reveals an industry poised for significant expansion over the coming years. Increasing Acceptance of Psychedelics in Medicine Recent years have witnessed […]

The FDA and Psychedelic Medicine: Approval Processes, Challenges and Outlook

With the renewed interest in using psychedelic substances for medical use comes an increased focus on navigating their complex regulatory framework, particularly that governing approval and use. The Food and Drug Administration (FDA) plays an integral part here by evaluating safety and efficacy, potential therapeutic use and future outlook of such medicines. This report investigates […]

Psychedelic Wellness Retreats: An Emerging Trend in Mental Health Tourism

Recently, there has been a remarkable shift in how mental health is perceived and treated around the globe. One particularly intriguing development in this regard has been an increase in interest for psychedelic wellness retreats as an emerging form of mental health tourism, providing participants with safe environments to experience therapeutic benefits of psychedelic substances […]

The Global Psychedelic Market: Regional Analysis and Market Opportunities

The global psychedelic market has experienced explosive growth over recent years, driven by advancements in research, increased public awareness, and changing attitudes about mental health treatments. Posing significant therapeutic potential, psychedelic substances are increasingly recognized for treating depression, anxiety, PTSD and addiction disorders – potential breakthrough treatments which psychedelic substances could radically transform. This report […]

Rick Doblin and MAPS: Shaping the Psychedelic Renaissance and Advocating for Legal Change

Rick Doblin, founder of the Multidisciplinary Association for Psychedelic Studies (MAPS), has been one of the key forces driving forward the current renaissance in psychedelic research and therapeutic use, advocating for medical and therapeutic use while pressing for legal change. Since 1986, MAPS has been at the forefront of research and education regarding these powerful […]

Neurobiology of Psychedelics: Understanding the Mechanics of the Mind

Researchers have recently been making strides towards understanding how psychedelics influence human brain and consciousness, seeking to unravel their complex effects on these substances and human consciousness. Findings from such inquiry not only holds great promise for revolutionizing our understanding of mind and consciousness but may also inspire novel treatments for many mental health disorders. […]

Atai Life Sciences: A Global Platform for Psychedelic Research and Development.

Atai Life Sciences is a pioneering biotech company dedicated to the research, development and commercialization of new treatments for mental health conditions. Offering global access and an impressive roster of therapeutic candidates, Atai is at the forefront of psychedelic renaissance; working to bring innovative solutions to millions suffering from treatment-resistant mental illnesses. In this article […]

Comparing Top Psychedelic Investments Based on Risk, Growth and Profitability

The psychedelic industry has experienced rapid expansion over the last several years due to increased public interest, innovative clinical research, and shifting legal landscapes. Investors are eager to capitalize on psychedelic medicine’s immense potential as well as those companies at the forefront of this burgeoning market; we will compare some of the top investments, taking […]

Pilot Course: Essential Business Foundations for Psychedelic Therapists

Join the waitlist for our pilot course today and start shaping a more effective practice.

We will never spam or sell your info. Ever.